1	PPARalpha	PPARalpha	_	_	_	_	_	_	_
2	activators	activator	_	_	_	_	_	_	_
3	inhibit	inhibit	_	_	_	_	_	_	_
4	cytokine-induced	cytokine-induced	_	_	_	_	_	_	_
5	vascular	vascular	_	_	_	_	_	_	_
6	cell	cell	_	_	_	_	_	_	_
7	adhesion	adhesion	_	_	_	_	_	_	_
8	molecule-1	molecule-1	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	endothelial	endothelial	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Adhesion	Adhesion	_	_	_	_	_	_	_
4	molecule	molecule	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	on	on	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	endothelial	endothelial	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	EC	EC	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	surface	surface	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	critical	critical	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	leukocyte	leukocyte	_	_	_	_	_	_	_
18	recruitment	recruitment	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	atherosclerotic	atherosclerotic	_	_	_	_	_	_	_
21	lesions	lesion	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Better	good	_	_	_	_	_	_	_
2	understanding	understanding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	transcriptional	transcriptional	_	_	_	_	_	_	_
5	regulation	regulation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	adhesion	adhesion	_	_	_	_	_	_	_
8	molecules	molecule	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	ECs	ec	_	_	_	_	_	_	_
11	may	may	_	_	_	_	_	_	_
12	provide	provide	_	_	_	_	_	_	_
13	important	important	_	_	_	_	_	_	_
14	insight	insight	_	_	_	_	_	_	_
15	into	into	_	_	_	_	_	_	_
16	plaque	plaque	_	_	_	_	_	_	_
17	formation	formation	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Peroxisome	Peroxisome	_	_	_	_	_	_	_
2	proliferator-activated	proliferator-activated	_	_	_	_	_	_	_
3	receptor-alpha	receptor-alpha	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	PPARalpha	PPARalpha	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	member	member	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	family	family	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	regulates	regulate	_	_	_	_	_	_	_
17	gene	gene	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	response	response	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	certain	certain	_	_	_	_	_	_	_
23	fatty	fatty	_	_	_	_	_	_	_
24	acids	acid	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	fibric	fibric	_	_	_	_	_	_	_
27	acid	acid	_	_	_	_	_	_	_
28	derivatives	derivative	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	present	present	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	investigated	investigate	_	_	_	_	_	_	_
5	PPARalpha	PPARalpha	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	ECs	ec	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	their	their	_	_	_	_	_	_	_
12	regulation	regulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	vascular	vascular	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	adhesion	adhesion	_	_	_	_	_	_	_
17	molecule-1	molecule-1	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	VCAM-1	vcam-1	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	AND	and	_	_	_	_	_	_	_
3	RESULTS	results	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	Immunohistochemistry	Immunohistochemistry	_	_	_	_	_	_	_
6	revealed	reveal	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	carotid	carotid	_	_	_	_	_	_	_
10	artery	artery	_	_	_	_	_	_	_
11	ECs	ec	_	_	_	_	_	_	_
12	express	express	_	_	_	_	_	_	_
13	PPARalpha	PPARalpha	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Pretreatment	Pretreatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	cultured	culture	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	ECs	ec	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	PPARalpha	PPARalpha	_	_	_	_	_	_	_
9	activators	activator	_	_	_	_	_	_	_
10	fenofibrate	fenofibrate	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	WY14643	WY14643	_	_	_	_	_	_	_
13	inhibited	inhibit	_	_	_	_	_	_	_
14	TNF-alpha-induced	tnf-alpha-induced	_	_	_	_	_	_	_
15	VCAM-1	vcam-1	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	time-	time-	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	concentration-dependent	concentration-dependent	_	_	_	_	_	_	_
21	manner	manner	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	an	an	_	_	_	_	_	_	_
24	effect	effect	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	seen	see	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	PPARgamma	PPARgamma	_	_	_	_	_	_	_
29	activators	activator	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	PPARalpha	PPARalpha	_	_	_	_	_	_	_
3	activators	activator	_	_	_	_	_	_	_
4	decreased	decrease	_	_	_	_	_	_	_
5	cytokine-induced	cytokine-induced	_	_	_	_	_	_	_
6	VCAM-1	vcam-1	_	_	_	_	_	_	_
7	mRNA	mrna	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	without	without	_	_	_	_	_	_	_
10	altering	alter	_	_	_	_	_	_	_
11	its	its	_	_	_	_	_	_	_
12	mRNA	mrna	_	_	_	_	_	_	_
13	half-life	half-life	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Transient	transient	_	_	_	_	_	_	_
2	transfection	transfection	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	deletional	deletional	_	_	_	_	_	_	_
5	VCAM-1	vcam-1	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	constructs	construct	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	electrophoretic	electrophoretic	_	_	_	_	_	_	_
10	mobility	mobility	_	_	_	_	_	_	_
11	shift	shift	_	_	_	_	_	_	_
12	assays	assay	_	_	_	_	_	_	_
13	suggest	suggest	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	fenofibrate	fenofibrate	_	_	_	_	_	_	_
16	inhibits	inhibit	_	_	_	_	_	_	_
17	VCAM-1	vcam-1	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	part	part	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	inhibiting	inhibit	_	_	_	_	_	_	_
23	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	PPARalpha	PPARalpha	_	_	_	_	_	_	_
4	activators	activator	_	_	_	_	_	_	_
5	significantly	significantly	_	_	_	_	_	_	_
6	reduced	reduce	_	_	_	_	_	_	_
7	adhesion	adhesion	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	U937	u937	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	cultured	culture	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	ECs	ec	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Human	human	_	_	_	_	_	_	_
4	ECs	EC	_	_	_	_	_	_	_
5	express	express	_	_	_	_	_	_	_
6	PPARalpha	PPARalpha	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	potentially	potentially	_	_	_	_	_	_	_
10	important	important	_	_	_	_	_	_	_
11	regulator	regulator	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	atherogenesis	atherogenesis	_	_	_	_	_	_	_
14	through	through	_	_	_	_	_	_	_
15	its	its	_	_	_	_	_	_	_
16	transcriptional	transcriptional	_	_	_	_	_	_	_
17	control	control	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	VCAM-1	vcam-1	_	_	_	_	_	_	_
20	gene	gene	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Such	such	_	_	_	_	_	_	_
2	findings	finding	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	have	have	_	_	_	_	_	_	_
5	implications	implication	_	_	_	_	_	_	_
6	regarding	regard	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	clinical	clinical	_	_	_	_	_	_	_
9	use	use	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	lipid-lowering	lipid-lowering	_	_	_	_	_	_	_
12	agents	agent	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	like	like	_	_	_	_	_	_	_
15	fibric	fibric	_	_	_	_	_	_	_
16	acids	acid	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	which	which	_	_	_	_	_	_	_
19	can	can	_	_	_	_	_	_	_
20	activate	activate	_	_	_	_	_	_	_
21	PPARalpha	PPARalpha	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

